Time to Call a Top in Biotech?
by Chris Johnson 02/20/09
Free Trading Guides
More Trading Ideas
One of the market's darling sectors has been biotechnology -- a group investors have bid higher in anticipation of potential changes by the new presidential administration.
The effect has been a relative strength leader that has bested the market by more than 30% during the past six months.
While I've liked a few of biotech companies, the sector's current situation causes some concern.
More By This Expert
Why Does My Call Decline When the Stock Gains?
Understanding the factors that affect option pricing is crucial to your trading success.
Use a Strangle to Profit From Starbucks' Earnings
Starbucks has been a big mover -- up and down -- after earnings, and the company is schedule to report today after the close A strangle creates a win-win for traders.
The earnings projections for Starwood Hotels (HOT) are ridiculously low. Get in before they blow expectations out of the water.
Bullish call activity in YHOO is hitting highs for the year ahead of earnings -- but when they announce it will be a wake, not a party.
XOM may hit earnings estimates, but a big, positive reaction is not likely to materialize, and the newbies will fall over themselves to dump the stock.
